Aditxt’s Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at ...
Money Talks News on MSN
Scientist Claims Humans Could Live 20,000 Years With New Technology
British scientist says humans could live 20,000 years through DNA reprogramming and cellular repair technology that ...
The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...
Insane Curiosity on MSN
How Researchers Are Trying to Turn Aging Into a Curable Disease
Across private labs and government projects, biologists are breaking down the mechanisms of aging — reprogramming cells, repairing DNA, and testing how far the human body can be pushed before it fails ...
Metabolic reprogramming in fibrotic lung diseases involves key metabolites like lactate, succinate, and 2-hydroxyglutarate, ...
Anti-aging biotech NewLimit plans to push a liver-rejuvenating mRNA medicine into the clinic with the aid of a $130 million series B fundraising round. The round was led by Kleiner Perkins alongside ...
Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (NASDAQ: ...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt”, or the “Company”), a social innovation platform accelerating promising health innovations, today announced an update on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback